Systematic, network-based characterization of therapeutic target inhibitors
Yao Shen,
Mariano J Alvarez,
Brygida Bisikirska,
Alexander Lachmann,
Ronald Realubit,
Sergey Pampou,
Jorida Coku,
Charles Karan and
Andrea Califano
PLOS Computational Biology, 2017, vol. 13, issue 10, 1-22
Abstract:
A large fraction of the proteins that are being identified as key tumor dependencies represent poor pharmacological targets or lack clinically-relevant small-molecule inhibitors. Availability of fully generalizable approaches for the systematic and efficient prioritization of tumor-context specific protein activity inhibitors would thus have significant translational value. Unfortunately, inhibitor effects on protein activity cannot be directly measured in systematic and proteome-wide fashion by conventional biochemical assays. We introduce OncoLead, a novel network based approach for the systematic prioritization of candidate inhibitors for arbitrary targets of therapeutic interest. In vitro and in vivo validation confirmed that OncoLead analysis can recapitulate known inhibitors as well as prioritize novel, context-specific inhibitors of difficult targets, such as MYC and STAT3. We used OncoLead to generate the first unbiased drug/regulator interaction map, representing compounds modulating the activity of cancer-relevant transcription factors, with potential in precision medicine.Author summary: Most transcription factors are considered “undruggable” in conventional drug discovery. However, a large number of them are discovered to be key tumor dependencies. Thus, targeting these difficult targets has been a challenge for cancer drug discovery. Here, we introduce a novel method, OncoLead, that applies biological networks to identify candidate inhibitors that either directly or in-directly block the activities of these targets. This approach is confirmed by known target-inhibitor interactions in public databases. Furthermore, we predicted new inhibitors for MYC and STAT3, which are validated by in vitro assays.
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005599 (text/html)
https://journals.plos.org/ploscompbiol/article/fil ... 05599&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pcbi00:1005599
DOI: 10.1371/journal.pcbi.1005599
Access Statistics for this article
More articles in PLOS Computational Biology from Public Library of Science
Bibliographic data for series maintained by ploscompbiol ().